AI, Autonomy and Regulation Drive Today’s Market Churn — Bionano LCD, CSBC Deal and Intuit’s AI Pivot Lead the Tape

A U.S.–Taiwan co‑production pact for autonomous surface vessels, a potential Medicare coverage pivot for Bionano Genomics, and Intuit’s ‘growth reset’ with an amplified AI push dominated headlines. Market moves were mixed: chip names and select stocks saw heavy volume while biotech litigation and regulatory notices added risk.